AI
SLNO

Atom Investors’s Soleno Therapeutics SLNO Stock Holding History

Atom Investors’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,550
Closed -$813K – 831
2025
Q4 		$813K Buy
+17,550
New +$962K 0.06% 325
2025
Q3 		– Sell
-11,777
Closed -$987K – 793
2025
Q2 		$987K Sell
11,777
-2,524
-18% -$189K 0.09% 249
2025
Q1 		$1.02M Buy
+14,301
New +$696K 0.13% 206
2024
Q1 		– Sell
-8,846
Closed -$356K – 663
2023
Q4 		$356K Buy
+8,846
New +$252K 0.06% 333

Other funds holding SLNO

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

Atom Investors's SLNO Position: Q1 2026 in Review

Atom Investors sold out of Soleno Therapeutics (SLNO) in Q1 2026, closing a stake of 17,550 shares — an estimated $813K sold.

Atom Investors first reported a position in SLNO in Q4 2023 and held it in 4 quarters. The position peaked at $1.02M in Q1 2025. 226 funds tracked by Wall St. Rank hold SLNO as of Q1 2026.

  • Atom Investors reported no remaining Soleno Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 17,550 Soleno Therapeutics shares in Q1 2026, an estimated $813K.
  • Atom Investors first reported a position in Soleno Therapeutics in Q4 2023 and held it in 4 quarters.
  • Atom Investors's Soleno Therapeutics position peaked at $1.02M in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.